FOXP3 and myelodysplastic syndrome: Despite this limitation, the tissue architecture was analyzed using antibodies directed against CD3, CD8, FOXP3, and MUM1p to label immune cell subsets and CD34 to label HSPC and MDS/sAML blasts.